SKHINCAPSProject reference: 685909
Funded under :
H2020-EU.220.127.116.11. - Ensuring the safe and sustainable development and application of nanotechnologies
H2020-EU.18.104.22.168. - Developing the societal dimension of nanotechnology
H2020-EU.22.214.171.124. - Developing and standardisation of capacity-enhancing techniques, measuring methods and equipment
SKin Healthcare by Innovative NanoCAPsuleS
SKHINCAPS project will explore an innovative and sustainable in situ self-assembly nanoencapsulation technology to deliver novel products for skin healthcare applications, with increased efficiency and cost benefits, leading to ground-breaking innovations on the actual products.
Using this safe, sustainable and easily scalable technology, different actives will be addressed for nanoencapsulation: phase-change materials (PCMs), a cocktail of vitamins and antioxidants, and natural essential oils. The nanocapsules will be engineered to achieve three possible release mechanisms, enhancing actives efficiency.
Different demonstrators will be developed with these customised and safe nanocapsules for skin healthcare applications:
- First layer garments with no-release nanocapsules loaded with PCMs, to improve thermal management and skin comfort;
- Creams with triggered nanocapsules containing the cocktail, to improve the anti-ageing effect on the end-users skin;
- Lotions and textiles containing targeted nanocapsules loaded with natural essential oils to prevent or even mitigate bacterial infections on the end-users skin.
These demonstrators will be fully tested for their safety and performance assessment to fulfil the present regulation requirements.
SKHINCAPS comprises SMEs from different stages of the supply chain, so it will promote stronger collaborations between materials suppliers, manufacturers and end-users. SKHINCAPS is therefore entirely aligned with the European 2020 strategy, contributing to boost competitiveness and support the creation of jobs and new sources of growth. SKHINCAPS is also committed with the flagships initiatives, and with a number of wider H2020 objectives including: control healthcare expenditure, H2020 strategic cosmeceuticals sector and plural H2020 Key Enabling Technologies (KETs).
EU contribution: EUR 567 941,34
RUA FERNANDO MESQUITA 2785
4760 034 VILA NOVA DE FAMALICAO
EU contribution: EUR 497 952,5
POLIGONO MOCHOLI, PLAZA CEIN 5
EU contribution: EUR 0
CALLE NICOLAS COPERNICO 7 PARQUE TECNOLOGICO
46980 PATERNA, VALENCIA
EU contribution: EUR 673 535
CALLE JORDI GIRONA 31
EU contribution: EUR 561 250
ERWIN-SCHROEDINGER-STRASSE GEB 58
EU contribution: EUR 195 417
RUA ENG FREDERICO ULR 2650
4470 605 MAIA
EU contribution: EUR 259 082,91
CALLE MOLI D EN BARRI 7
08415 BIGUES I RIELLS
EU contribution: EUR 293 887,5
Rue Beeckman 119
EU contribution: EUR 216 854,5